Top Updates Back
Nipro Medical Corporation ProdutosMedicos LTDA.
Injection Systems
Hospital Supplies
Renal Care
General Hospital Supplies
Pharmaceutical Packaging
Diabetes Care
Home Infusion Therapy
Vascular
iMEP - Institute for Medical Practice
Infection Control
Blood Glucose Testing
Elastomeric Infusion Pump
Intravenous Therapy Device
Interventional Cardiology
Intravascular Imaging
Cardiovascular Diagnosis
Medical Training & Education
Infection Control Solutions
Enzymes
Vascular Care
LiniXia
NephroFlow Product Suite
Makoto Intravascular Imaging System
Surefuser+
CLFine
Pre-fillable Glass Syringes
Cardiovascular Solutions
Therapeutic
Accessories
Medical device manufacturing
Disposable medical equipment manufacturing
Needle manufacturing
Infusion system manufacturing
Blood collection system manufacturing
Injection system manufacturing
Vascular retrieval system manufacturing
Syringe manufacturing
Safety device manufacturing
Standard IV Catheter
Infusion systems
Product support
Customer service
Product information
IFUs
Expertise
Trainings
Laboratory services
Medical Devices
Primary packaging
Scoring balloon catheter
Vascular products
Therapeutic products
200 Commons Blvd, Second Floor, Bridgewater, NJ 08807
Company name
Group Parent Subsidiary Customer Supplier Alliance Bank Shareholder
NIPRO Corporation Japan
Group company Parent Subsidiary Customer Supplier Alliance Bank, lending and credit Investment, equity and shareholders
Group
Nipro Europe Group Companies
Group company Parent Subsidiary Customer Supplier Alliance Bank, lending and credit Investment, equity and shareholders
Group

29 entries
DateDescription
1954 Established in 1954
1954 Established in 1954, Nipro PharmaPackaging is a leading global manufacturer of comprehensive pharma packaging solutions for the pharmaceutical industry.
1990 Listed in the First Section of the Osaka Securities Exchange.
1990 Developed fully (integrated) kit of antibiotics with a major pharmaceutical manufacturer.
1991 European headquarters established in Belgium.
1994 Established manufacturing site in China.
1995 Integrated kits were now being sold.
1995 Established manufacturing site in Brazil.
1996 Listed in the First Section of the Tokyo Stock Exchange.
1996 Established commercial branch in the United States.
1997 Prefilled syringes were now being sold.
1997 Established manufacturing site in Singapore.
2001 Change of name to Nipro Corporation.
2005 Entered into the oxygenator market.
2005 Expanded pharmaceutical business to include solid formulations.
2007 Began integrated production: from the spinning of hollow fiber membranes to the production of dialyzers.
2009 Entered into culture-medium-related products.
2010 Established manufacturing sites in India.
2010 Expanded diabetes-related business in the United States and medical glass in China.
2011 Established manufacturing sites in Bangladesh and Indonesia.
2011 Expanded pharma packaging glass production in France, Russia, and the United States.
2012 Expanded pharma packaging glass production in Germany.
2014 Opening of iMEP Japan, medical training center.
2014 Expanded into cell culture business.
2015 Expanded into drug testing business.
2015 Pharma packaging glass production in China.
2018 Opening of iMEP Belgium, medical training center.
2018 European headquarters moved to Nipro Campus Belgium (new HQ building + iMEP).
2019 Continuous integration and optimization of global sites.
+ Loaded when opened
✅
2026-09-21 18:10 (Model: ggml-org/gpt-oss-20b )
↑